CN101554441A - Traditional Chinese medicine for treating coronary heart disease - Google Patents
Traditional Chinese medicine for treating coronary heart disease Download PDFInfo
- Publication number
- CN101554441A CN101554441A CNA2008101035939A CN200810103593A CN101554441A CN 101554441 A CN101554441 A CN 101554441A CN A2008101035939 A CNA2008101035939 A CN A2008101035939A CN 200810103593 A CN200810103593 A CN 200810103593A CN 101554441 A CN101554441 A CN 101554441A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- heart disease
- coronary heart
- traditional chinese
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention belongs to the field of traditional Chinese medicines for treating heart disease, provides a traditional Chinese medicine for treating coronary heart disease and aims at achieving favorable effect and quick response. The traditional Chinese medicine is prepared from kudzuvine root, notoginseng, szechuan lovage rhizome, glossy ganoderma, Chinese angelica, omoto nipponlily rhizome, wild jujube, and the like, has the functions of strengthening healthy energy, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis, and generating favorable effect and quick response and has the advantages of marked effect, determined curative effect and quicker response.
Description
Technical field
The invention belongs to the cardiopathic field of Chinese medicines of treatment.
Background technology
Be intended to treat the field of Chinese medicines of coronary heart disease at present, have the deficiency of two aspects: the one, effect is obvious inadequately; The 2nd, it is slower to take effect.Many patients with coronary heart disease are stood the torment of feeling of oppression and pain in the chest for a long time, face the danger of myocardial infarction, and patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of coronary heart disease, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, it is remarkable to have effect, determined curative effect, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
A kind of Chinese medicine for the treatment of coronary heart disease is taked the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Puerariae 0.3-2.6 part Radix Notoginseng 0.2-1.9 part Rhizoma Chuanxiong 0.3-2.5 part
Ganoderma 0.15-1 part Radix Angelicae Sinensis 0.3-2.5 part Omoto Nipponlily Rhizome 0.2-1.9 part
Semen Ziziphi Spinosae 0.2-1.9 part
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Radix Puerariae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Omoto Nipponlily Rhizome, Semen Ziziphi Spinosae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The traditional Chinese medical science thinks that coronary heart disease is the resistance of the arteria coronaria stasis of blood, due to promoting the circulation of blood is not smooth, controls and works as Qi-benefiting and heart-nourishing, blood circulation promoting and blood stasis dispelling.Ganoderma QI invigorating in the side, the tonification the five internal organs; Chinese Angelica blood replonishing is invigorated blood circulation; Radix Notoginseng, Rhizoma Chuanxiong, Radix Puerariae blood circulation promoting and blood stasis dispelling; 5 with the diuresis of Omoto Nipponlily Rhizome heart tonifying; The Semen Ziziphi Spinosae calming soporific.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and the merit of blood circulation promoting and blood stasis dispelling, effective, instant effect, it is remarkable to have effect, determined curative effect, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Puerariae 50 gram Radix Notoginseng 40 gram Rhizoma Chuanxiongs 60 grams
Ganoderma 30 gram Radix Angelicae Sinensis 62 gram Omoto Nipponlily Rhizomes 42 grams
Semen Ziziphi Spinosae 36 grams
Weight in accordance with regulations, with conventional water extraction process Radix Puerariae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Omoto Nipponlily Rhizome, Semen Ziziphi Spinosae are extracted, make extractum fine powder 87.5 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 562 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Puerariae 125 gram Radix Notoginseng 96 gram Rhizoma Chuanxiongs 145 grams
Ganoderma 72 gram Radix Angelicae Sinensis 135 gram Omoto Nipponlily Rhizomes 96 grams
Semen Ziziphi Spinosae 96 grams
By above-mentioned same method, make 1346 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Puerariae 260 gram Radix Notoginseng 190 gram Rhizoma Chuanxiongs 250 grams
Ganoderma 100 gram Radix Angelicae Sinensis 250 gram Omoto Nipponlily Rhizomes 190 grams
Semen Ziziphi Spinosae 190 grams
By above-mentioned same method, make 2142 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
24 parts of 18 parts of Rhizoma Chuanxiongs of 22 portions of Radix Notoginseng of Radix Puerariae
17 parts of 23 parts of Omoto Nipponlily Rhizomes of 09 part of Radix Angelicae Sinensis of Ganoderma
19 parts of Semen Ziziphi Spinosaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
52 parts of 36 parts of Rhizoma Chuanxiongs of 45 portions of Radix Notoginseng of Radix Puerariae
44 parts of 60 parts of Omoto Nipponlily Rhizomes of 32 parts of Radix Angelicae Sinensis of Ganoderma
44 parts of Semen Ziziphi Spinosaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science coronary heart disease, through 18 routine clinical observations.Selecting tcm diagnosis coronary heart disease is standard: have a delicate constitution, limb is soft weak, and feeling of oppression and pain in the chest is dizzy nervous, the Electrocardioscopy myocardial ischemia.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 11 examples, women's 7 examples do not have other serious disease, and the age is 32 years old-69 years old, 51.7 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, cardiac distresses such as feeling of oppression and pain in the chest are obviously alleviated, and the visible blood supply of cardiac muscle of electrocardiogram obviously improves.
2, effective: body constitution strengthens, and cardiac distresses such as feeling of oppression and pain in the chest are alleviated to some extent, and electrocardiogram sees that blood supply of cardiac muscle obviously makes moderate progress.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 3 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom has clear improvement.18 philtrums of clinical experiment, produce effects 7 people, effective 9 people, invalid 2 people, total effective rate 88.8%.
Claims (1)
- A kind of Chinese medicine for the treatment of coronary heart disease is characterized in that: it is made with the weight ratio of following component, and its component proportioning is:Radix Puerariae 0.3-2.6 part Radix Notoginseng 0.2-1.9 part Rhizoma Chuanxiong 0.3-2.5 partGanoderma 0.15-1 part Radix Angelicae Sinensis 0.3-2.5 part Omoto Nipponlily Rhizome 0.2-1.9 partSemen Ziziphi Spinosae 0.2-1.9 partThe Chinese medicine of this treatment coronary heart disease is made by following method:(1) by above-mentioned weight ratio, Radix Puerariae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Omoto Nipponlily Rhizome, Semen Ziziphi Spinosae are extracted through conventional water extraction process, make the extractum fine powder;(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008101035939A CN101554441A (en) | 2008-04-09 | 2008-04-09 | Traditional Chinese medicine for treating coronary heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008101035939A CN101554441A (en) | 2008-04-09 | 2008-04-09 | Traditional Chinese medicine for treating coronary heart disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101554441A true CN101554441A (en) | 2009-10-14 |
Family
ID=41172823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008101035939A Pending CN101554441A (en) | 2008-04-09 | 2008-04-09 | Traditional Chinese medicine for treating coronary heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101554441A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101843793B (en) * | 2009-11-25 | 2011-08-17 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating tachycardia |
-
2008
- 2008-04-09 CN CNA2008101035939A patent/CN101554441A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101843793B (en) * | 2009-11-25 | 2011-08-17 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating tachycardia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101554470A (en) | Traditional Chinese medicine for treating tachycardia | |
CN101564505B (en) | Chinese medicament for treating pulmonary heart disease | |
CN101537121B (en) | Chinese medicine for treating arteriosclerosis | |
CN101554443B (en) | Traditional Chinese medicine for treating angina | |
CN101537114B (en) | Chinese medicine for treating arrhythmia | |
CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
CN101554441A (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN101843755A (en) | Chinese medicament for treating diabetic cardiopathy | |
CN101843717B (en) | Chinese medicament for treating coronary disease | |
CN101537061B (en) | Chinese medicine for treating liver cancer | |
CN101843660A (en) | Chinese medicament for treating tachycardia | |
CN101537068B (en) | Chinese medicine for treating angina | |
CN101843832B (en) | Chinese medicament for treating coronary disease | |
CN101843835B (en) | Chinese medicament for treating coronary diseases | |
CN101843758B (en) | Chinese medicament for treating coronary disease | |
CN101843700A (en) | Chinese medicament for treating coronary disease | |
CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
CN101530501B (en) | Traditional Chinese medicine for treating diabetic anemia | |
CN101843793B (en) | Chinese medicament for treating tachycardia | |
CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
CN101554412A (en) | Traditional Chinese medicine for treating atrial fibrillation | |
CN101843741A (en) | Chinese medicament for treating femoral head necrosis | |
CN101897847A (en) | Traditional Chinese medicine for curing asthma | |
CN101554426A (en) | Traditional Chinese medicine for treating diabetic obstipation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20091014 |